Xencor

Xencor is a Pasadena-based biotechnology company relevant as a strategic life-sciences capital provider rather than a conventional VC fund. It develops XmAb antibody and Fc-domain protein engineering technologies across oncology, autoimmune disease and infectious disease, and is most relevant for U.S. later-stage biotech, life sciences and pharmaceutical companies seeking antibody-engineering or drug-development alignment.